|
Market Closed -
Nasdaq
04:30:00 2026-10-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.7540 USD | +1.11% |
|
-2.08% | -33.86% |
| Oct. 26 | Top Premarket Gainers | MT |
| Oct. 12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 13.1M | - | - | - | ||
| 249B | |||||
| 162B | |||||
| 157B | |||||
| 66.22B | |||||
| 52.3B |
- Stock Market
- Stocks
- IRIX Stock
- Charts IRIDEX Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
